Patent · US Active

Semaglutide in medical therapy

US12295988B2 · kind B2 · utility

0Cited by
13References
1Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 30, 2024
Grant dateMay 13, 2025
Priority date
Expiry dateAug 30, 2044

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K9/0019
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to semaglutide for use in weight management.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.